Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natural Protein A), Application (Antibody Purification, Immunoprecipitation), & End User - Global Forecast to 2025
The protein A resin market is expected to reach USD 1.9 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 11.4% during the forecast period. The protein A resin market has witnessed increasing consumption due to increased monoclonal antibody production on account of the pandemic situation worldwide.
Growth in the market can primarily be attributed to factors such as demand for pre-packed disposable columns, increasing demand for therapeutic antibodies, and increasing pharmaceutical R&D spending
“The agarose-based protein A segment to hold the largest market share in 2020.”
Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. . In 2020, the agarose-based protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.
“The recombinant protein A segment to hold the largest market share in 2020.”
Based on type, the protein A resin market is segmented into recombinant protein A and natural protein. In 2020, the recombinant protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributedto the frequent use of recombinant protein A resins during the production of monoclonal antibodies.
“The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.”
Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users. In 2020, the pharmaceutical and biopharmaceutical companiessegment is expected to command the largest share of the protein A resin market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global protein A resin market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Break of primary participants was as mentioned below:
Research Coverage
This report studies the protein A resin market based on product,type, application, end-user, and region. The report also studies the different factors (such as drivers, restraints,challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the protein A resinmarket, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the protein A resin market and garner greater market shares.
Growth in the market can primarily be attributed to factors such as demand for pre-packed disposable columns, increasing demand for therapeutic antibodies, and increasing pharmaceutical R&D spending
“The agarose-based protein A segment to hold the largest market share in 2020.”
Based on product, the protein A resin market is segmented into agarose-based protein A, glass/silica-based protein A, and organic polymer-based protein A. . In 2020, the agarose-based protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributed to the agarose being the most widely used matrix resin for the attachment of ligands that bind proteins.
“The recombinant protein A segment to hold the largest market share in 2020.”
Based on type, the protein A resin market is segmented into recombinant protein A and natural protein. In 2020, the recombinant protein A segment is expected to command the largest share of the protein A resin market. The large share of this segment can be attributedto the frequent use of recombinant protein A resins during the production of monoclonal antibodies.
“The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.”
Based on end user, the protein A resin market is segmented into pharmaceutical & biopharmaceutical companies, academic research institutes, and other end users. In 2020, the pharmaceutical and biopharmaceutical companiessegment is expected to command the largest share of the protein A resin market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.
“The Asia Pacific region to witness the highest growth during the forecast period.”
Geographically, North America dominated the global protein A resin market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include increased R&D activities, as APAC has emerged as a key pharmaceutical and biopharmaceutical research hub. Considering this, a number of key pharmaceutical and biopharmaceutical companies have set up their research centers in the region. Also, local major players such as Ranbaxy, Dr. Reddy’s, Cipla, Lupin, and Cadila are actively involved in research on biosimilars and generic drugs.
Break of primary participants was as mentioned below:
- By Company Type: Tier I: 40%, Tier II: 30%, Tier III: 30%
- By Designation:C-Level Executives: 27%, Directors:18%, Others: 55%
- By Region:North America: 40%, Europe: 20%, Asia Pacific : 30%, Latin America: 8%, Middle-East: 2%
Research Coverage
This report studies the protein A resin market based on product,type, application, end-user, and region. The report also studies the different factors (such as drivers, restraints,challenges, and opportunities) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the protein A resinmarket, and their drivers, restraints, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the protein A resin market and garner greater market shares.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.3.1 MARKETS COVERED
FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE REPORT
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH METHODOLOGY: PROTEIN A RESIN MARKET
FIGURE 3 RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19-SPECIFIC ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 9 PROTEIN A RESIN MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PROTEIN A RESIN MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PROTEIN A RESIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 12 PROTEIN A RESIN MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN A RESIN MARKET
4 PREMIUM INSIGHTS
4.1 GLOBAL PROTEIN A RESIN MARKET OVERVIEW
FIGURE 14 ADVANTAGES OF PROTEIN A RESINS HAVE DRIVEN THEIR ADOPTION
4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, 2019
FIGURE 15 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
4.3 PROTEIN A RESIN MARKET, BY PRODUCT & SERVICE
FIGURE 16 AGAROSE-BASED PROTEIN A SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020
4.4 PROTEIN A RESIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Growing demand for disposable pre-packed columns
TABLE 1 ADVANTAGES OF PRE-PACKED COLUMNS
5.2.1.2 Increasing demand for therapeutic antibodies
5.2.1.3 Increasing pharmaceutical R&D spending
5.2.2 RESTRAINTS
5.2.2.1 High cost of resins
5.2.2.2 Dearth of skilled professionals
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing number of CMOs and CROs
FIGURE 19 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET GROWTH, 2019–2024
5.2.3.2 Increasing demand for biosimilars
FIGURE 20 GROWTH OF THE BIOSIMILARS MARKET, 2018–2023
TABLE 2 LIST OF KEY BIOLOGICS UNDER THE THREAT OF PATENT EXPIRY
5.3 PRICING ANALYSIS: PROTEIN A RESIN MARKET
5.4 PORTER’S FIVE FORCES ANALYSIS
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF SUBSTITUTES
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 THREAT OF NEW ENTRANTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 IMPACT OF COVID-19 ON THE PROTEIN A RESIN MARKET
5.6 VALUE CHAIN ANALYSIS
FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.6.1 RESEARCH & DEVELOPMENT
5.6.2 MANUFACTURING & ASSEMBLY
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.7 SUPPLY CHAIN ANALYSIS
5.7.1 PROMINENT COMPANIES
5.7.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.7.3 END USERS
FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 24 ECOSYSTEM ANALYSIS OF THE PROTEIN A RESIN MARKET
6 PROTEIN A RESIN MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 3 PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 AGAROSE-BASED PROTEIN A
6.2.1 BENEFITS OFFERED BY AGAROSE MAKES IT THE PREFERRED CHOICE FOR PROTEIN PURIFICATION
TABLE 4 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 APAC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 GLASS/SILICA-BASED PROTEIN A
6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH
TABLE 8 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 APAC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 ORGANIC POLYMER-BASED PROTEIN A
6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH
TABLE 12 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 APAC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 PROTEIN A RESIN MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 16 PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2 RECOMBINANT PROTEIN A
7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH
TABLE 17 RECOMBINANT PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 NATURAL PROTEIN A
7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED THE MARKET POTENTIAL OF NATURAL PROTEIN A
TABLE 21 NATURAL PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 APAC: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8 PROTEIN A RESIN MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 25 PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 ANTIBODY PURIFICATION
8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 26 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2018–2025 (USD MILLION)
8.3 IMMUNOPRECIPITATION
8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT A LOWER CAGR DURING THE FORECAST PERIOD
TABLE 27 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2018–2025 (USD MILLION)
9 PROTEIN A RESIN MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
9.2.1 PROTEIN A RESIN IS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS
FIGURE 25 SPENDING ON BIOPHARMACEUTICAL RESEARCH, 2005–2020 (USD BILLION)
TABLE 29 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
9.3 ACADEMIC RESEARCH INSTITUTES
9.3.1 BOOMING R&D IN DRUG DISCOVERY LIKELY TO INCREASE THE USE OF PROTEIN A RESINS
TABLE 30 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9.4 OTHER END USERS
TABLE 31 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
10 PROTEIN A RESIN MARKET, BY REGION
10.1 INTRODUCTION
TABLE 32 PROTEIN A RESIN MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Booming R&D investment in the pharmaceutical industry to propel market growth
TABLE 38 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 39 US: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 US: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 41 US: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives focused on boosting the pharmaceutical industry to drive market growth
TABLE 42 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 43 CANADA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 CANADA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 45 CANADA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 EUROPE
FIGURE 27 EUROPE: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 46 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Flourishing biotechnology industry in the country to drive market growth
TABLE 51 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 52 GERMANY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 54 GERMANY: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Favorable R&D scenario in the country to support market growth
TABLE 55 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 56 UK: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 UK: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 58 UK: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Favorable healthcare scenario to boost market growth in France
TABLE 59 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 60 FRANCE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Well-established pharmaceutical industry in the country to spur the demand for protein A resins
TABLE 63 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 64 ITALY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 ITALY: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 66 ITALY: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Presence of a large number of biotech R&D service providers to support market growth
TABLE 67 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 68 SPAIN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 71 ROE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 72 ROE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ROE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 ROE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 28 APAC: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 75 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 77 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars is driving resin consumption in the country
TABLE 80 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 JAPAN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 JAPAN: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 83 JAPAN: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increased pharmaceutical R&D spending to drive market growth
TABLE 84 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 85 CHINA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 CHINA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 CHINA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growth of the pharma and biotech industries is leading to high demand for protein A resins in India
TABLE 88 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 89 INDIA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 INDIA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 INDIA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 92 ROAPAC: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 93 ROAPAC: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
FIGURE 29 ROW: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 96 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 99 ROW: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 30 KEY DEVELOPMENTS IN THE PROTEIN A RESIN MARKET, 2017–2019
11.2 MARKET SHARE ANALYSIS
FIGURE 31 PROTEIN A RESIN MARKET SHARE ANALYSIS (2019)
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
FIGURE 32 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES
TABLE 100 PRODUCT LAUNCHES (2017–2020)
11.4.2 FUNDING
TABLE 101 FUNDING (2017–2020)
11.4.3 ACQUISITIONS
TABLE 102 ACQUISITIONS (2017–2020)
11.4.4 PARTNERSHIPS
TABLE 103 PARTNERSHIPS (2017–2020)
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
12.1 GE HEALTHCARE
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT
12.2 MERCK MILLIPORE
FIGURE 34 MERCK MILLIPORE: COMPANY SNAPSHOT
12.3 REPLIGEN CORPORATION
FIGURE 35 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2019)
12.4 THERMO FISHER SCIENTIFIC, INC.
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
12.5 TOSOH BIOSCIENCE
FIGURE 37 TOSOH CORPORATION: COMPANY SNAPSHOT
12.6 PUROLITE CORPORATION
12.7 NOVASEP HOLDING SAS
12.8 AGILENT TECHNOLOGIES, INC.
FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
12.9 GENSCRIPT BIOTECH CORPORATION
FIGURE 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018)
12.10 PERKINELMER, INC.
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT
12.11 BIO-RAD LABORATORIES, INC.
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
12.12 OROCHEM
12.13 ANEKA CORPORATION
FIGURE 42 KANEKA CORPORATION: COMPANY SNAPSHOT
12.14 ABCAM PLC.
12.15 AGAROSE BEAD TECHNOLOGIES
12.16 AVANTOR, INC.
12.17 JSR LIFE SCIENCES
12.18 BIO-WORKS TECHNOLOGIES
12.19 TAKARA BIO
12.20 GENERON
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.3.1 MARKETS COVERED
FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE REPORT
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH METHODOLOGY: PROTEIN A RESIN MARKET
FIGURE 3 RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19-SPECIFIC ASSUMPTIONS
3 EXECUTIVE SUMMARY
FIGURE 9 PROTEIN A RESIN MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 PROTEIN A RESIN MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 11 PROTEIN A RESIN MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 12 PROTEIN A RESIN MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE PROTEIN A RESIN MARKET
4 PREMIUM INSIGHTS
4.1 GLOBAL PROTEIN A RESIN MARKET OVERVIEW
FIGURE 14 ADVANTAGES OF PROTEIN A RESINS HAVE DRIVEN THEIR ADOPTION
4.2 NORTH AMERICA: PROTEIN A RESIN MARKET, 2019
FIGURE 15 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
4.3 PROTEIN A RESIN MARKET, BY PRODUCT & SERVICE
FIGURE 16 AGAROSE-BASED PROTEIN A SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2020
4.4 PROTEIN A RESIN MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Growing demand for disposable pre-packed columns
TABLE 1 ADVANTAGES OF PRE-PACKED COLUMNS
5.2.1.2 Increasing demand for therapeutic antibodies
5.2.1.3 Increasing pharmaceutical R&D spending
5.2.2 RESTRAINTS
5.2.2.1 High cost of resins
5.2.2.2 Dearth of skilled professionals
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing number of CMOs and CROs
FIGURE 19 PHARMACEUTICAL CONTRACT MANUFACTURING MARKET GROWTH, 2019–2024
5.2.3.2 Increasing demand for biosimilars
FIGURE 20 GROWTH OF THE BIOSIMILARS MARKET, 2018–2023
TABLE 2 LIST OF KEY BIOLOGICS UNDER THE THREAT OF PATENT EXPIRY
5.3 PRICING ANALYSIS: PROTEIN A RESIN MARKET
5.4 PORTER’S FIVE FORCES ANALYSIS
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF SUBSTITUTES
5.4.2 BARGAINING POWER OF SUPPLIERS
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 THREAT OF NEW ENTRANTS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 IMPACT OF COVID-19 ON THE PROTEIN A RESIN MARKET
5.6 VALUE CHAIN ANALYSIS
FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.6.1 RESEARCH & DEVELOPMENT
5.6.2 MANUFACTURING & ASSEMBLY
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.7 SUPPLY CHAIN ANALYSIS
5.7.1 PROMINENT COMPANIES
5.7.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.7.3 END USERS
FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
FIGURE 24 ECOSYSTEM ANALYSIS OF THE PROTEIN A RESIN MARKET
6 PROTEIN A RESIN MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 3 PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
6.2 AGAROSE-BASED PROTEIN A
6.2.1 BENEFITS OFFERED BY AGAROSE MAKES IT THE PREFERRED CHOICE FOR PROTEIN PURIFICATION
TABLE 4 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 5 NORTH AMERICA: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 EUROPE: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 APAC: AGAROSE-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.3 GLASS/SILICA-BASED PROTEIN A
6.3.1 LOW PH TOLERANCE OF SILICA-BASED RESINS TO LIMIT THEIR MARKET GROWTH
TABLE 8 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 APAC: GLASS/SILICA-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
6.4 ORGANIC POLYMER-BASED PROTEIN A
6.4.1 INCREASING POPULARITY OF ORGANIC POLYMERS TO DRIVE MARKET GROWTH
TABLE 12 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 APAC: ORGANIC POLYMER-BASED PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7 PROTEIN A RESIN MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 16 PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2 RECOMBINANT PROTEIN A
7.2.1 COST-EFFICIENCY OF RECOMBINANT PROTEINS TO DRIVE MARKET GROWTH
TABLE 17 RECOMBINANT PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 NORTH AMERICA: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 EUROPE: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 APAC: RECOMBINANT PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
7.3 NATURAL PROTEIN A
7.3.1 ADVANTAGES OF RECOMBINANT PROTEIN A HAVE RESTRICTED THE MARKET POTENTIAL OF NATURAL PROTEIN A
TABLE 21 NATURAL PROTEIN A MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 APAC: NATURAL PROTEIN A MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
8 PROTEIN A RESIN MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 25 PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
8.2 ANTIBODY PURIFICATION
8.2.1 ANTIBODY PURIFICATION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 26 PROTEIN A RESIN MARKET FOR ANTIBODY PURIFICATION, BY REGION, 2018–2025 (USD MILLION)
8.3 IMMUNOPRECIPITATION
8.3.1 IMMUNOPRECIPITATION SEGMENT TO GROW AT A LOWER CAGR DURING THE FORECAST PERIOD
TABLE 27 PROTEIN A RESIN MARKET FOR IMMUNOPRECIPITATION, BY REGION, 2018–2025 (USD MILLION)
9 PROTEIN A RESIN MARKET, BY END USER
9.1 INTRODUCTION
TABLE 28 PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
9.2.1 PROTEIN A RESIN IS EXTENSIVELY USED TO PRODUCE BIOLOGICAL DRUGS
FIGURE 25 SPENDING ON BIOPHARMACEUTICAL RESEARCH, 2005–2020 (USD BILLION)
TABLE 29 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
9.3 ACADEMIC RESEARCH INSTITUTES
9.3.1 BOOMING R&D IN DRUG DISCOVERY LIKELY TO INCREASE THE USE OF PROTEIN A RESINS
TABLE 30 PROTEIN A RESIN MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
9.4 OTHER END USERS
TABLE 31 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
10 PROTEIN A RESIN MARKET, BY REGION
10.1 INTRODUCTION
TABLE 32 PROTEIN A RESIN MARKET, BY REGION, 2018–2025 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.1 US
10.2.1.1 Booming R&D investment in the pharmaceutical industry to propel market growth
TABLE 38 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 39 US: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 US: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 41 US: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Government initiatives focused on boosting the pharmaceutical industry to drive market growth
TABLE 42 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 43 CANADA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 CANADA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 45 CANADA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3 EUROPE
FIGURE 27 EUROPE: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 46 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Flourishing biotechnology industry in the country to drive market growth
TABLE 51 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 52 GERMANY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 GERMANY: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 54 GERMANY: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.2 UK
10.3.2.1 Favorable R&D scenario in the country to support market growth
TABLE 55 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 56 UK: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 UK: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 58 UK: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Favorable healthcare scenario to boost market growth in France
TABLE 59 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 60 FRANCE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 FRANCE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 FRANCE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Well-established pharmaceutical industry in the country to spur the demand for protein A resins
TABLE 63 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 64 ITALY: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 ITALY: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 66 ITALY: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Presence of a large number of biotech R&D service providers to support market growth
TABLE 67 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 68 SPAIN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 SPAIN: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 70 SPAIN: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 71 ROE: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 72 ROE: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 ROE: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 ROE: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 28 APAC: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 75 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 77 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 78 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Increasing demand for generic drugs and monoclonal antibody biosimilars is driving resin consumption in the country
TABLE 80 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 JAPAN: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 JAPAN: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 83 JAPAN: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increased pharmaceutical R&D spending to drive market growth
TABLE 84 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 85 CHINA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 CHINA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 87 CHINA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growth of the pharma and biotech industries is leading to high demand for protein A resins in India
TABLE 88 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 89 INDIA: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 INDIA: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 INDIA: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 92 ROAPAC: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 93 ROAPAC: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 94 ROAPAC: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 95 ROAPAC: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
10.5 REST OF THE WORLD
FIGURE 29 ROW: PROTEIN A RESIN MARKET SNAPSHOT
TABLE 96 ROW: PROTEIN A RESIN MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 97 ROW: PROTEIN A RESIN MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ROW: PROTEIN A RESIN MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 99 ROW: PROTEIN A RESIN MARKET, BY END USER, 2018–2025 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 30 KEY DEVELOPMENTS IN THE PROTEIN A RESIN MARKET, 2017–2019
11.2 MARKET SHARE ANALYSIS
FIGURE 31 PROTEIN A RESIN MARKET SHARE ANALYSIS (2019)
11.3 COMPETITIVE LEADERSHIP MAPPING
11.3.1 VISIONARY LEADERS
11.3.2 INNOVATORS
11.3.3 DYNAMIC DIFFERENTIATORS
11.3.4 EMERGING COMPANIES
FIGURE 32 PROTEIN A RESIN MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES
TABLE 100 PRODUCT LAUNCHES (2017–2020)
11.4.2 FUNDING
TABLE 101 FUNDING (2017–2020)
11.4.3 ACQUISITIONS
TABLE 102 ACQUISITIONS (2017–2020)
11.4.4 PARTNERSHIPS
TABLE 103 PARTNERSHIPS (2017–2020)
12 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
12.1 GE HEALTHCARE
FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT
12.2 MERCK MILLIPORE
FIGURE 34 MERCK MILLIPORE: COMPANY SNAPSHOT
12.3 REPLIGEN CORPORATION
FIGURE 35 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2019)
12.4 THERMO FISHER SCIENTIFIC, INC.
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
12.5 TOSOH BIOSCIENCE
FIGURE 37 TOSOH CORPORATION: COMPANY SNAPSHOT
12.6 PUROLITE CORPORATION
12.7 NOVASEP HOLDING SAS
12.8 AGILENT TECHNOLOGIES, INC.
FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
12.9 GENSCRIPT BIOTECH CORPORATION
FIGURE 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2018)
12.10 PERKINELMER, INC.
FIGURE 40 PERKINELMER, INC.: COMPANY SNAPSHOT
12.11 BIO-RAD LABORATORIES, INC.
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
12.12 OROCHEM
12.13 ANEKA CORPORATION
FIGURE 42 KANEKA CORPORATION: COMPANY SNAPSHOT
12.14 ABCAM PLC.
12.15 AGAROSE BEAD TECHNOLOGIES
12.16 AVANTOR, INC.
12.17 JSR LIFE SCIENCES
12.18 BIO-WORKS TECHNOLOGIES
12.19 TAKARA BIO
12.20 GENERON
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
